Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.163742690058479 0.0526315789473683 0.105263157894737
Stock impact report

AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells

AgeX Therapeutics, Inc. (AGE) 
Company Research Source: Business Wire
First research collaboration for immunotolerance UniverCyteTM technology platform, marking launch of new business development and collaboration strategySecures milestone collaboration in Japan, where cell therapy R&D is advancing rapidly in a favourable regulatory and commercial environmentUniverCyte platform has potential to deliver cells as therapeutics that do not require immunosuppressive therapy ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today a research collaboration with a Japanese biopharma company utilizing AgeX’s HLA-G-based immunotolerance UniverCyteTM technology platform for the engineering of hypoimmunogenic (universal) cells. The research program will evaluate the expression of UniverCyte on induced pluripotent stem cells (iPS cells) and the ability of those UniverCyte-modified iPS cells to evade immune responses and to differentiate Show less Read more
Impact Snapshot
Event Time:
AGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AGE alerts
Opt-in for
AGE alerts

from News Quantified
Opt-in for
AGE alerts

from News Quantified